The Tina’s Wish Scientific Advisory Board (SAB) provides scientific direction and guidance to the Foundation in connection with its mission. The SAB board is closely involved in the Foundation’s grant recommendations and annual grant review process. Read more about Tina’s Wish Grants here. The SAB also works with the Rita M. Kirpalani Consortium grantees.
|DOUGLAS LEVINE, MD
Dr. Levine is the Director of Gynecologic Oncology, Head of the Gynecology Research Laboratory and a Professor at NYU Langone Perlmutter Cancer Center. Prior to joining the NYU Langone Medical Center team, Dr. Levine was an Associate Attending Surgeon at Memorial Sloan Kettering Cancer Center in New York City. He received his M.D. from Mount Sinai School of Medicine and completed his residency at Mount Sinai Medical Center and a fellowship at Memorial Sloan Kettering. In addition to his clinical practice, Dr. Levine studies cancer prevention, precision medicine, and rare tumors with unmet needs. Dr. Levine brings to Tina’s Wish an outstanding level of expertise and leadership in ovarian cancer research and a deep commitment to women’s health.
To read about Dr. Levine’s funded research click here.
ROBERT BURGER, MD
Robert Burger is Director of Clinical Research and Fellowship Program in Gynecologic Oncology and Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania. He received his MD from New York University School of Medicine and completed his residency at the Hospital of the University of Pennsylvania and a fellowship at UC, Irvine Medical Center. Dr. Burger is newly appointed to the Tina’s Wish Scientific Advisory Board.
DR. PAUL CLEARY, PhD
Paul Cleary is Dean of the Yale School of Public Health, Professor of Sociology and the Anna M.R. Lauder Professor of Public Health at the Yale University School of Medicine. Dr. Cleary is also Principal Investigator and Director of the Yale Center for Interdisciplinary Research on AIDS (CIRA). He received both his MS and his PhD in sociology from the University of Wisconsin. Dr. Cleary has served on the Tina’s Wish Board of Directors since its inception.
JOYCE LIU, MD, MPH
Joyce Liu joined the staff of Dana-Farber and Brigham and Women’s Hospital in 2008, where she is a medical oncologist and clinical investigator in the Gynecologic Oncology Program. She received her MD from Harvard Medical School and completed her residency in Internal Medicine at Brigham and Women’s Hospital, and her fellowship in Hematology Oncology at the Dana-Farber Cancer Institute. Dr. Liu’s research focuses on identifying and validating potential therapeutic targets in advanced platinum-resistant ovarian cancer, in an in-vitro setting as well as in a murine xenograft model of ovarian cancer. Dr. Liu is newly appointed to the Tina’s Wish Scientific Advisory Board.
Dr. Liu has recently been awarded The Columbia Hospital Research Foundation Annual Award for Research Excellence in Breast, Obstetrical and Gynecologic Disorders. Read Article > Read more about the Award >
In the 5th issue of Dana-Farber’s Inside the Institute, Dr. Liu discusses the importance of federal funding after her successful clinical trial, which was funded by the National Cancer Institute, proved that a novel two-drug combination nearly doubled progression-free survival for many women with ovarian cancer.